Skip to main content

Relation of the left ventricular geometric patten to coronary artery disease in hypertensive patients using a 320-detector-row CT scanner

Abstract

Background

It was estimated that about 1.3 billion people were diagnosed to be hypertensive in 2015. All countries consistently show this high prevalence. Ischemic heart disease stands as the most common cause of systolic blood pressure-related deaths per year. Left ventricular hypertrophy determined by echocardiography can predict cardiovascular morbidity and mortality. The question of whether the LV geometric pattern has an additional prognostic value is still not clearly answered. Currently, coronary computed tomography is widely used in clinical practice with a great capability of simultaneous evaluation of the LV mass and the coronary arterial tree. Our study aims to examine the relationship between LV mass and geometry and coronary artery disease using an ECG-gated 320-detector- row CT scanner.

Results

Two hundred ninety-eight hypertensive Egyptian individuals were enrolled in our study, the mean age was 57.5 ± 10.5, and males comprised 76.5% of the study population. The mean LV mass and LV mass index were 193 ± 60 gm and 95.2 ± 27.5 g/m2 respectively. One-fifth of the patient had CAD luminal stenosis ≥ 50%. Normal LV geometric pattern was observed in about 37% of the study population. About one-third of the patients showed concentric remodeling. Patients with increased LV mass index represented one-third of the study population with a greater percentage of the concentric hypertrophy pattern than the eccentric hypertrophy pattern. Patients with high CAD-RADS showed statistically significant higher LV mass, LV mass index, and septal wall thickness. Patients with high CAD-RADS showed a greater percentage of concentric and eccentric hypertrophy. The LV geometric pattern was the only independent predictor of the high CAD-RADS. The LV geometric patterns associated with high RADS ordered from the highest to the lowest, were concentric LVH, Eccentric LV, and concentric remodeling.

Conclusions

LV geometric pattern is the only independent predictor of high CAD-RADS after adjustment for LV mass index and septal wall thickness. Among abnormal LV geometric patterns, concentric hypertrophy stands as the most important predictor of high CAD-RADS.

Background

It was estimated that about 1.3 billion people were diagnosed to be hypertensive based on office blood pressure in 2015. All countries consistently show this high prevalence irrespective of their economic status [1, 2].

The disability-adjusted life years owing to hypertension have increased by 40% since 1990. Ischemic heart disease stands as the most common cause of systolic blood pressure-related deaths per year [3].

Chest X-ray and ECG are insensitive techniques for the detection of left ventricular hypertrophy. On the other hand, LVH determined by echocardiography has a well-established prognostic value in predicting cardiovascular morbidity and mortality [4,5,6,7,8,9,10,11].

The geometric pattern of hypertrophy of the left ventricle associated with arterial hypertension is identified by calculating the LV mass and the relative wall thickness. The question of whether the LV geometric pattern has an additional prognostic value is still not clearly answered [10, 12,13,14].

Coronary computed tomography is widely used in clinical practice for the non-invasive evaluation of the coronary arterial tree. The three-dimensional capability of the ECG-gated CT study allowed for the simultaneous, accurate evaluation of the LV volumes and mass. Its accuracy has been validated against cardiac magnetic resonance imaging –the gold standard for LV volume and structure assessment– in previous studies [15,16,17,18,19].

Our study aims to examine the relationship between LV mass and geometry and coronary artery disease using an ECG-gated 320-detector- row CT scanner that can simultaneously evaluate the coronary arterial tree and the LV chamber size and mass.

Methods

Study design and population

This is a prospective, non-randomized, cross-sectional, observational study that enrolled 298 hypertensive patients scheduled for MSCT coronary angiography for suspected coronary artery disease.

Consent for publication

All patients gave written informed consent to publish the data contained within this study.

Inclusion criteria

Hypertensive Individuals aged over 30 years who were scheduled for MSCT coronary angiography. Hypertension is defined as office BP measurements of SBP ≥ 140 mmHg and/or diastolic BP (DBP) ≥ 90 mmHg [20].

Exclusion criteria

  1. 1.

    Diabetes mellitus (DM), dyslipidemia, or smoking.

  2. 2.

    Valvular heart disease.

  3. 3.

    Cardiomyopathy.

  4. 4.

    Previous coronary artery bypass (CABG) or percutaneous coronary intervention (PCI).

  5. 5.

    Individuals who refuse to participate in this study.

Study design

  1. 1.

    Clinical assessment: All individuals were subjected to focused medical history and clinical examination with emphasis on the following:

    1. a.

      Demographic characteristics and anthropometric measurements:

    • Age and genderb-Cardiovascular risk factors: DM, dyslipidemia, and smoking.

    • Height measurement using the standing height scaleb-Cardiovascular risk factors: DM, dyslipidemia, and smoking.

    • Body weight and body mass index (BMI). The latter was calculated using the following formula: BMI = body weight in kg / height in m2). Adults were classified according to BMI (table adapted from WHO Consultation on Obesity): Underweight < 18.5 Normal range 18.5–24.9 Overweight 25–29.9 Obese class I 30–34.9 Obese class II 35–39.9 Obese class III ≥ 40 [21].b-Cardiovascular risk factors: DM, dyslipidemia, and smoking.

    • Body surface area (BSA): This was calculated using Du Bois formula: BSA = 0.007184 × weight in kg0.425 × height in cm0.725.b-Cardiovascular risk factors: DM, dyslipidemia, and smoking.

  2. 2.

    Multi-slice CT Angiogram (MSCT) Study Protocol:

A retrospective, ECG-gated multi-slice CT coronary angiography was done using a 320-slice, Toshiba Aquilion one machine (Kern: FC43, spacing 0.25 mm, FOV 240 mm, thickness 0.5 mm, 120 kV, 450 mA). After acquiring the non-contrast enhanced sequence, a high flow rate injection of ''A patient-weight tailored contrast dose ''average of 75 ml of non-ionic contrast (5.3 ml/sec.) via an anti-cubital vein was done, followed by the acquisition of ultra-thin cardiac sections to evaluate the coronary arteries. The study was evaluated at the systolic and diastolic phases (75% and 40% of the cardiac cycle, respectively). Selective reconstruction of the poorly visualized segments of the coronary arteries at different phases of the cardiac cycle was done. Coronary artery disease reporting and data system (CAD- RADS) was used to standardize our reports [22].

Additional images to evaluate the LV diameters, LV wall thickness, and LV volume was reconstructed during diastole with increments of 5% from 75 to 90% of the RR interval. Data were transferred to a workstation with commercial software (Vitrea FX, version 6.1, Vital Images, Minnetonka, MN, USA) for analysis. Multi-planar reformation (MPR) images of the LV cardiac chamber (including short-axis, 4-chamber, and 2-chamber views) were automatically generated.

The LV volumes were calculated by automatic detection of the LV epicardial and endocardial borders by the software without the inclusion of the papillary muscles (Fig. 1). Both borders could be corrected by the reader (expert cardiologist) if necessary. The end-diastolic phase was defined as the largest LV volume. These estimates were used to calculate the LV myocardial mass (g) ([epicardial volume—endocardial volume] × 1.04 g/mL), where 1.04 is the myocardial density. The LV mass was normalized using BSA (m2). The cutoffs of 115 g/m2 for men and 95 g/m2 for women were used to define the presence of LVH [23, 24].

Fig. 1
figure 1

Assessment of the LV mass by automatic contouring of the endocardial and epicardial borders with slight manual correction, taken at the end-diastole (80% of the cardiac cycle)

The LV end-diastolic inner dimension (LVID, cm) on the 4-chamber multi-planar reformatted images (MPR), LV wall thickness; both the septum (septal wall thickness [SWT], cm) and the posterior wall (PWT, cm) on the short-axis MPR at the chorda level were measured (Fig. 2). The relative wall thickness was calculated as (RWT [cm] = 2 × PWT / LVID). A value of > 42% was defined as abnormal [23, 24].

Fig. 2
figure 2

Measurement of the LV wall thickness (both the septum and posterior wall) in the short axis at the level of the chordea (A) and the left ventricle end-diastolic inner diameter in the four-chamber view (B)

The patients were classified into four groups of geometric patterns based on the values of LV mass index and RWT: normal (normal LV mass and normal RWT), concentric remodeling (normal LV mass and increased RWT), eccentric LVH (increased LV mass and normal RWT), and concentric LVH (increased LV mass and RWT) [25]. To assess the inter-observer variability, the first 20 subjects were analyzed by two experienced readers (two cardiologists who are experts in cardiac imaging).

Statistical methodology

After data collection, analysis was done using Statistical Package of Social Science (SPSS) version 19. Categorical data were displayed as numbers and percentages and continuous data were displayed as means ± SD (for normally distributed data) or median and range (for abnormally distributed data). Comparison analysis was conducted using student’s t-test (for data that were normally distributed) or a Mann–Whitney test (for data that were not normally distributed) and a Pearson Chi-square test (for categorical variables). Multiple linear regression analysis was used to predict significant CAD. A two-tailed P-value < 0.05 was considered significant.

Reproducibility

CT data (CT coronary angiography and LV measurements) of the first twenty patients were repeated by the same operator one week later to test for intra-observer variability, and the intra-observer correlation coefficient ranged from 0.88 to 0.98. The CT data of the same twenty patients was measured by another operator to test for inter-observer variability and the intra-observer correlation coefficient ranged from 0.89 to 0.97.

Results

This non-randomized, observational, cross-sectional study was conducted in Cairo, Egypt from November 2019 to November 2021. This study enrolled 298 Egyptian patients who underwent CT coronary angiography for suspected CAD.

Demographics and baseline clinical characteristics of the study population

Two hundred and ninety-eight Egyptian individuals were enrolled in our study. The mean age was 57.5 ± 10.5, males comprised 76.5% of the study population, the mean weight and height were 87.6 ± 15.7 kg and 171.1 ± 8.0cm respectively, the mean BMI was 29.6 ± 5.1 cm2/kg and the mean BSA was 20 ± 0.2 m2. About two-thirds of the study population were overweight or mildly obese. These data are presented in tables 1 and 2.

Table 1 Baseline clinical data of the study population
Table 2 Obesity distribution among the study population

The mean LV mass and mean LV mass index were 193 ± 60 gm and 95.2 ± 27.5 g/m2 respectively. The CAD RADS score shows a median of 2. Only 20% of the patient had CAD luminal stenosis ≥ 50%. Normal LV geometric pattern was observed in about 37% of the study population. About one-third of the patients showed concentric remodeling. Patients with increased LV mass index represented one-third of the study population with a greater percentage of the concentric hypertrophy pattern than the eccentric hypertrophy pattern (table 3 and 4).

Table 3 Baseline CT data of the study population
Table 4 CAD severity according to the Society of Cardiovascular Computed Tomography (SCCT)

Comparison analysis

According to the result of the MSCT coronary angiography, the patients were classified into a group with less than 50% luminal diameter stenosis (CAD- RADS 0,1 and 2) and a group with 50% or more luminal diameter stenosis (CAD- RADS 3,4 and 5). A comparison between both groups was conducted (Table 5). Patients with high CAD-RADS showed higher LV mass, LV mass index, and septal wall thickness, with all three being statistically significant (Fig. 3). Patients with high CAD-RADS showed a greater percentage of concentric and eccentric hypertrophy while patients with lower CAD-RADS showed a greater percentage of normal and concentric remodeling patterns (Fig. 4).

Table 5 Comparison between patients with CAD-RADS < 3 and those with CAD-RADS ≥ 3
Fig. 3
figure 3

Comparison between patients with CAD-RADS < 3 vs. those with CAD-RADS ≥ 3 regarding LV mass index (panel A) and septal wall thickness (panel B)

Fig. 4
figure 4

Comparison of the LV geometric pattern between patients with CAD-RADS < 3 vs. those with CAD-RADS ≥ 3

A one-way ANOVA was conducted to compare LV mass index across the different LV geometric patterns (Fig. 5). It showed statistically significant differences between the four groups; normal, concentric remodeling, eccentric hypertrophy, and concentric hypertrophy (Table 6). Of note, post hoc analysis using Bonferroni showed no significant difference in the LV mass index between concentric hypertrophy and eccentric hypertrophy. On the contrary, there was a significant difference between all the other groups (Table 7).

Fig. 5
figure 5

Comparison of the four LV geometric patterns regarding the LV mass index

Table 6 Comparison between the four LV geometric pattern regarding the LV mass index
Table 7 Comparison in-between the different LV geometric patterns regarding the LV mass index

Correlation analysis

There is a statistically significant weak correlation between relative wall thickness and LV mass index. This finding raises the importance of LV geometric patterns beyond the LV mass index in our analysis (Fig. 6).

Fig. 6
figure 6

Correlation between LV mass index and relative wall thickness

Regression analysis

Stepwise multiple linear regression analysis was conducted to predict the severity of coronary artery disease (Table 8). Among septal wall thickness, LV mass index, and LV geometric, the LV geometric pattern was the only independent predictor of the higher CAD-RADS (R = 0.22. adjusted R square = 0.05, P = 0.002) (Fig. 7).

Table 8 Linear Regression Analysis to predict CAD-RADS ≥ 3
Fig. 7
figure 7

Regression analysis to predict significant CAD, CAD-RADS ≥ 3

Conducting multiple linear regression analysis (Table 9) had shown that LV geometric patterns associated with high RADS ordered from the highest to the lowest, were concentric LVH, Eccentric LV, and concentric remodeling (Fig. 8).

Table 9 Linear Regression Analysis of the abnormal LV geometric patterns to predict CAD-RADS ≥ 3
Fig. 8
figure 8

Regression analysis to show the relative importance of the different geometric patterns

Discussion

This is the first study to investigate the relationship between CAD using CAD-RADS and both LV mass and its geometric patterns in hypertensive patients using a 320-detector-row CT scanner.

Hypertension consistently shows high prevalence in all countries irrespective of their socio-economic status. The disability-adjusted life years due to hypertension has increased by 40% since 1990. Ischemic heart disease stands as the most common cause of systolic blood pressure-related deaths per year [1,2,3].

Coronary computed tomography angiography (CCTA) is a widely available, clinically validated, noninvasive imaging tool that is used to evaluate the coronary arterial tree. CAD-RADS is a standardized system for reporting the CCTA results. It has the advantages of improving communication with the referring physicians and facilitating research work, resulting in better patient care and outcomes [22]. CCTA using the wide-detector CT scanner (320-detector-row CT scanner), besides assessing the coronary arteries, has also allowed for obtaining accurate volumetric data of the cardiac chambers, especially the left ventricle (LV) [26, 27].

Left ventricular hypertrophy determined by echocardiography is an independent risk factor for increased cardiovascular morbidity and mortality. This well-established relationship is continuous and graded [7,8,9,10,11, 28, 29].

Koren et al. and Muiesan et al. conducted two prospective studies including relatively healthy adults with essential hypertension, following them up for ten years. Levy et al. also conducted a prospective study that included Framingham study participants without prevalent cardiovascular disease with four years of follow-up. The three studies showed an adverse prognostic value of LVH determined by echocardiography using different cardiovascular disease endpoints, but all included MI [7, 10, 30].

Tang et al. conducted a non-randomized study on the members of the National Heart, Lung, and Blood Institute Family Heart Study and the Hypertension Genetic Epidemiologic Network study. They found a significant association between coronary artery calcium score (CAC) and LV mass index. This relationship was stronger in African Americans than whites [31].

Altunkan et al. conducted a study on two hundred forty-nine asymptomatic hypertensive patients. They found a direct relationship between LVH and coronary artery calcium where patients who were CAC positive showed significantly greater LVM than those who were CAC negative [32].

Mintu et al. conducted an observational study on one thousand and sixteen patients with coronary heart disease and a follow up period of three and half years. They found that LV mass index adjusted for clinical and other echocardiographic parameters was significantly associated with both all-cause mortality and sudden or arrhythmic death. This association maintained its significance even in patients with normal LV systolic function (defined as more than 55%) [33].

In agreement with the previously mentioned studies, our study using a 320-detector-row CT scanner showed that LV mass, LV mass index, and septal wall thickness were significantly higher in patients with significant coronary artery disease (CAD-RAD ≥ 3) than in those with non-obstructive CAD (CAD-RADS < 3). This finding confirms the significant relationship between LVH and CAD with the use of a wide detector CT scanner.

Despite representing different hemodynamic loads with different pathophysiologic mechanisms, the body of evidence that supports the prognostic value of the LV geometric pattern beyond LV mass is small, less clear, and sometimes contradictory [10, 14, 27, 34, 35].

Koren et al. first reported the prognostic value of the LV geometric pattern in patients with uncomplicated essential hypertension. The mortality rate over a follow-up period of 10 years was highest in patients with concentric LVH, followed by patients with eccentric hypertrophy and concentric remodeling (24%, 10%, and 6% respectively) [10].

Verdecchia et al. confirmed the adverse prognosis of concentric remodeling in 694 hypertensive patients, even after adjustment for several covariates (age, gender, diabetes, left ventricular mass index, and blood pressure) [12]. One year later, Verdecchia et al. published a study on hypertensive patients with LVH, where he couldn't confirm the prognostic value for the LV geometric pattern beyond that of the LV mass [14].

In the Framingham Heart Study, three thousand two hundred and sixteen Caucasian population sample had been investigated and followed up for 8 years. The outcome events were incident cardiovascular disease and death. The event rates were greatest in the concentric LVH group and lowest in the group with normal geometric pattern in both genders. However, this association eroded after adjustment for the LV mass [13].

The LIFE echo sub-study investigated nine hundred and sixty-three patients with a mean age of 66 years. One hundred and forty-nine patients had CAD and eight hundred and fourteen did not. The definition of CAD in this study was clinical, history of angina pectoris, myocardial infarction, or electrocardiographic evidence of myocardial infarction. This definition may underestimate the true prevalence of CAD. This study found that the prevalence of eccentric hypertrophy was significantly higher in patients with CAD [35].

Ghali et al. investigated nine hundred and eighty-eight predominantly African American hypertensive patients. The definition of CAD was the presence of at least one vessel with seventy percent diameter narrowing or more by conventional coronary angiography in multiple projections. They were followed up for a mean of nine years. They found that all-cause mortality increased progressively with different LV geometric patterns (normal pattern, concentric remodeling, eccentric hypertrophy, and concentric hypertrophy, sorted in ascending order). Cardiac deaths increased progressively from eccentric to concentric hypertrophy. The adjusted relative risk and 95% confidence of interval of cardiac death were significantly increased in patients with concentric hypertrophy (RR 2.21 to 297 for patients with and without CAD respectively). Patients with eccentric hypertrophy showed a moderate increase in cardiac death (RR 1.3 to 2.87 for patients with and without CAD respectively). Of note, concentric remodeling was not associated with an increase in the relative risk of cardiac death (RR 0.98 and 0.73 for those with or without CAD, respectively) [34].

Altunkan et al. found that significantly more patients with LV concentric hypertrophy had a positive CAC (57% of the patients in this group) compared to other LV geometric patterns. There was no significant difference in the number of CAC-positive patients among the other groups (eccentric hypertrophy, concentric remodeling, and normal group). In addition, the patient in the concentric hypertrophy group shows an average coronary calcium score (315 ± 761) that is significantly higher than other groups [32].

Uçar et al. studied two hundred and fifty hypertensive patients who underwent invasive coronary angiography. Coronary angiography was performed to investigate suspected ischemic heart disease based on clinical indications. The cumulative SYNTAX score (SS) was calculated to show the complexity and extent of CAD. They found that patients with concentric hypertrophy show the highest SS compared to other groups with a P-value of less than 0.05. Patients with eccentric hypertrophy show significantly higher SS than patients with concentric remodeling and normal geometry. Patients with concentric remodeling and normal geometry showed similar SS. Of note, concentric LV hypertrophy was the most important independent predictor of SS by regression analysis [37].

The previously mentioned studies investigated different types of populations with different study designs. The outcomes were all-cause mortality, cardiovascular mortality, or coronary artery disease. The extent of CAD was used as a surrogate for increased cardiovascular mortality. In the previous studies, multiple methods were used for CAD assessment; clinical, non-invasive (stress ECG37, nuclear imaging33, or electron beam CT to measure CAC), or invasive coronary angiography. There were also limitations regarding the methodology, the small number of patients in each LV geometric pattern, and the low? number of outcome events.

In our study, patients with high CAD-RADS showed a significantly higher percentage of abnormal LV geometric patterns (concentric and eccentric hypertrophy represent 65% of this group) while patients with low CAD-RADS showed a higher percentage of normal and concentric remodeling patterns (about 60% of this group). Patients with normal LV geometry is the predominant pattern in patients with low CAD-RADS (about one-third) and is the least predominant pattern (about 15%) in those with high CAD-RADS.

Among septal wall thickness, LV mass index, and LV geometry, LV geometric pattern was the only independent predictor of the high CAD-RADS (R = 0.22. adjusted R square = 0.05, P = 0.002). LV concentric hypertrophy is the most important predictor of high CAD-RADS (standardized co-efficient of 0.22, P = 0.001) followed by eccentric hypertrophy (standardized co-efficient of 0.16, P = 0.01) and lastly concentric remodeling (standardized co-efficient of 0.22, P = 0.001). There was no significant difference in the LV mass index between the LV concentric hypertrophy group and the LV eccentric hypertrophy group which confirms the independent role of LV concentric hypertrophy in predicting high CAD-RADS. The weak correlation between LV mass index and relative wall thickness emphasizes the independent adverse prognostic value of concentric remodeling in patients with lower LV mass index (normal pattern and concentric remodeling).

The LV geometric pattern in hypertensive patients shows a graded association with CAD: Concentric LV hypertrophy shows the highest cardiovascular risk, followed by eccentric hypertrophy and then concentric remodeling. The normal LV geometric pattern is associated with the lowest cardiovascular risk. Therefore, hypertension should be viewed as a disease with different subgroups, each heralding a different prognosis.

Limitation

  • Cardiac CT, despite being more accurate than echocardiography (overcoming the problems of operator dependency, poor window, and the assumption of a uniform LV wall thickness in two-dimensional echocardiography) cannot be used for routine assessment of the LV mass due to the risk of radiation, cost, and availability

  • The effect of patient gender could not be addressed in our study.

  • Dividing the patients into four LV geometric patterns and separating them based on CAD-RADS led to a small number in each group. Therefore, a larger number of patients in each group is needed to strengthen our results.

Conclusions

Abnormal LV geometric pattern (concentric and eccentric hypertrophy) is associated with high CAD-RADS. Among septal wall thickness, LV mass index, and LV geometry, the LV geometric pattern is the only independent predictor of high CAD-RADS. LV concentric hypertrophy is the most important predictor of high CAD-RADS, followed by eccentric hypertrophy then concentric remodeling. Therefore, assessment of the LV geometric pattern with the use of a wide scanner CT can improve the risk stratification of patients with hypertension.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ANOVA:

Analysis of variance

BMI:

Body mass index

BSA:

Body surface area

CAC:

Coronary artery calcium

CAD:

Coronary artery disease

CAD-RADS:

Coronary artery disease reporting and data system

CT:

Computed tomography

ECG:

Electrocardiogram

FOV:

Field of view

g:

Gram

Kv:

Kilo volt

LV:

Left ventricle

LVID:

Left LV end-diastolic inner dimension

LVH:

Left ventricular hypertrophy

mA:

Milliampere

m:

Meter

MSCT:

Multi-slice computed tomography

MPR:

Multi-planar reformatted

SWT:

Septal wall thickness

RWT:

Relative wall thickness

SCCT:

Society of cardiovascular computed tomography

SD:

Standard deviation

SPSS:

Statistical Package of Social Science

SWT:

Septal wall thickness

SS:

SYNTAX score

WHO:

World health organization

References

  1. NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2017; 389:37–55

  2. Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, Kazmi K, Lanas F, Wei L, Lopez-Jaramillo P, Fanghong L, Ismail NH, Puoane T, Rosengren A, Szuba A, Temizhan A, Wielgosz A, Yusuf R, Yusufali A, McKee M, Liu L, Mony P, Yusuf S, PURE Study Investigators. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310:959–968

  3. Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Barnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catala-Lopez F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ (2017) Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 317:165–182

    Article  PubMed  Google Scholar 

  4. Chikos PM, Figley MM, Fisher L (1977) Correlation between chest film and angiographic assessment of left ventricular size. AJR 128:367–373

    Article  CAS  PubMed  Google Scholar 

  5. Pewsner D, Jüni P, Egger M, Battaglia M, Sundström J, Bachmann LM (2007) Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 335(7622):711–719

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hancock EW, Deal BJ, Mirvis DM et al (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am CollCardiol 53(11):992–1002

    Article  Google Scholar 

  7. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1989) Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Study. Ann Intern Med 110:101–108

    Article  CAS  PubMed  Google Scholar 

  8. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M (1990) Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 65:441–445

    Article  CAS  PubMed  Google Scholar 

  9. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566

    Article  CAS  PubMed  Google Scholar 

  10. Koren MJ, Devereux RB, Casale PN, Savage DD, Laregh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345–352

    Article  CAS  PubMed  Google Scholar 

  11. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS (1992) The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 117:831–836

    Article  CAS  PubMed  Google Scholar 

  12. Verdecchia P, Schillaci G, Borgioni C et al (1995) Adverse prognostic significance of concentric remodelling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 25:871–878

    Article  CAS  PubMed  Google Scholar 

  13. Krumholz HM, Larson M, Levy D (1995) Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 25:879–884

    Article  CAS  PubMed  Google Scholar 

  14. Verdecchia P, Schillaci G, Borgioni C et al (1996) Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 78:197–202

    Article  CAS  PubMed  Google Scholar 

  15. Lin FY, Min JK (2008) Assessment of cardiac volumes by multidetector computed tomography. J Cardiovasc Comput Tomogr 2:256–262

    Article  PubMed  Google Scholar 

  16. Mahnken AH, Bruners P, Schmidt B, Bornikoel C, Flohr T, Günther RW (2009) Left ventricular function can reliably be assessed from dual-source CT using ECG-gated tube current modulation. Invest Radiol 44:384–389

    Article  PubMed  Google Scholar 

  17. Juergens KU, Grude M, Maintz D, Fallenberg EM, Wichter T, Heindel W et al (2004) multi-detector row CT of left ventricular function with dedicated analysis software versus MR imaging: initial experience. Radiology 230:403–410

    Article  PubMed  Google Scholar 

  18. Raman SV, Shah M, McCarthy B, Garcia A, Ferketich AK (2006) Multi-detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonance. Am Heart J 151:736–744

    Article  PubMed  Google Scholar 

  19. Asferg C, Usinger L, Kristensen TS, Abdulla J (2012) Accuracy of multi-slice computed tomography for measurement of left ventricular ejection fraction compared with cardiac magnetic resonance imaging and two-dimensional transthoracic echocardiography: a systematic review and meta-analysis. Eur J Radiol 81:e757–e762

    Article  PubMed  Google Scholar 

  20. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I (2018) ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013(34):2159–2219

    Google Scholar 

  21. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1–253

  22. Cury RC, Abbara S, Achenbach S, Agatston A, Berman DS, Budoff MJ, Dill KE, Jacobs JE, Maroules CD, Rubin GD, Rybicki FJ, Schoepf UJ, Shaw LJ, Stillman AE, White CS, Woodard PK, Leipsic JA (2020) Endorsed by the American College of Cardiology. J Cardiovasc Comput Tomogr 10(4):269–281

    Article  Google Scholar 

  23. Stolzmann P, Scheffel H, Leschka S, Schertler T, Frauenfelder T, Kaufmann PA et al (2008) Reference values for quantitative left ventricular and left atrial measurements in cardiac computed tomography. Eur Radiol 18:1625–1634

    Article  PubMed  Google Scholar 

  24. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270

    Article  PubMed  Google Scholar 

  25. Ganau A, Devereux RB, Roman MJU et al (1992) Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 19:1550–1558

    Article  CAS  PubMed  Google Scholar 

  26. Fuchs A, Mejdahl MR, Kuhl JT, Stisen ZR, Nilsson EJP, Køber LV, Børge G, Nordestgaard KKF (2016) Normal values of left ventricular mass and cardiac chamber volumes assessed by 320-detector computed tomography angiography in the Copenhagen General Population Study. Eur Heart J Cardiovasc Imag 17:1009–1017

    Article  Google Scholar 

  27. Kang EJ, Lee KN, Choi WJ, Kim YD, Shin KM, Lim JK, Lee J (2017) Left ventricular functional parameters and geometric patterns in korean adults on coronary CT angiography with a 320-detector-row CT scanner. Korean J Radiol 18(4):664–673

    Article  PubMed  PubMed Central  Google Scholar 

  28. Casale PN, Devereux RB, Milner M et al (1986) Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105:173–178

    Article  CAS  PubMed  Google Scholar 

  29. Aronow WS, Epstein S, Koenigsberg M, Schwartz KS (1988) Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden death in elderly patients. Am J Cardiol 62:1124–1125

    Article  CAS  PubMed  Google Scholar 

  30. Muiesan ML, Salvetti M, Rizzoni D et al (1995) Association of change in left ventricular mass with prognosis during long-term antihyperten-sive treatment. J Hypertens 13:1091–1095

    Article  CAS  PubMed  Google Scholar 

  31. Tang W, Arnett DK, Province MA, Lewis CE, North K, Carr JJ, Pankow JS, Hopkins PN, Devereux RB, Wilk JB, Wagenknecht L; Investigators of the FHS and HyperGEN. Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network. Am J Cardiol. 2006;97(10):1441–8

  32. Altunkan S, Erdogan N, Altin L, Budoff MJ (2003) Relation of coronary artery calcium to left ventricular mass and geometry in patients with essential hypertension. Blood Press Monit 8(1):9–15

    Article  PubMed  Google Scholar 

  33. Turakhia MP, Schiller NB, Whooley MA (2008) Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol 102(9):1131–1135

    Article  PubMed  PubMed Central  Google Scholar 

  34. Ghali JK, Liao Y, Cooper RS (1998) Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol 31:1635–1640

    Article  CAS  PubMed  Google Scholar 

  35. Zabalgoitia M, Berning J, Koren MJ, StØylen A, Devereux RB (2001) Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (The LIFE Study). Am J Cardiol 88:646–650

    Article  CAS  PubMed  Google Scholar 

  36. Uçar H, Gür M, Börekçi A, Yıldırım A, Baykan AO, Yüksel Kalkan G, Koç M, Şeker T, Coşkun M, Şen Ö, Çaylı M (2015) Relationship between extent and complexity of coronary artery disease and different left ventricular geometric patterns in patients with coronary artery disease and hypertension. Anatol J Cardiol 15(10):789–794

    Article  PubMed  Google Scholar 

  37. Gatzka CD, Cameron JD, Kingwell BA, Dart AM (1998) Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 32(3):575–578

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Nothing to be declared.

Author information

Authors and Affiliations

Authors

Contributions

AS, revised interpretation of the CT studies, revised data analysis and statistics and contributor in writing the manuscript. MA, collected the patients, and was also responsible for data processing and contributor in writing the manuscript. RH, revised interpretation of the CT studies and shared in reproducibility of the CT data. HE, contributor in writing the manuscript. YK, the idea of the study and was a contributor in writing the manuscript. All authors have read and approved the manuscript for submission.

Corresponding author

Correspondence to Ahmed Shehata Mohamed Ismail.

Ethics declarations

Ethics approval and consent to participate

All procedures performed in this study were in accordance with the ethical standards, approved by the ethics committee of Cairo University Hospitals, and complied with the Declaration of Helsinki 1964 and its latter amendments. Written informed consent was obtained from all individual participants included in this study. The ethics committee reference numbers are not available, as the study was started two years ago and ended 14 months latter, the numbers were not collected at the time of start and couldn’t be reached now.

Consent for publication

All patients included in this research gave written informed consent to publish the data contained within this study.

Competing interests

The authors declare that they have no competing interests

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ismail, A.S.M., Aouf, M.A., Diab, R.H. et al. Relation of the left ventricular geometric patten to coronary artery disease in hypertensive patients using a 320-detector-row CT scanner. Egypt Heart J 75, 34 (2023). https://doi.org/10.1186/s43044-023-00360-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43044-023-00360-7

Keywords